Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 03, 2015 7:18 AM ET

Biotechnology

Company Overview of Cantex Pharmaceuticals, Inc.

Company Overview

Cantex Pharmaceuticals, Inc., a biotechnology company, engages in developing cancer treatments. It offers ODSH, a low anticoagulant heparin derivative that reduces the incidence, severity, and duration of reduction of platelet counts caused by chemotherapy. The company also provides Disulfiram-Copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions, including proteasome inhibition, induction of reactive oxygen species, and strong inhibition of ALDH and the NF Kappa B pathways for metastatic breast cancer, pancreatic cancer, and glioblastoma. Cantex Pharmaceuticals, Inc. was formerly known as PARINGENIX INC. The company was incorporated in 2002 and is based...

1792 Bell Tower Lane

Suite 222

Weston, FL 33326

United States

Founded in 2002

Phone:

954-315-3660

Fax:

954-315-3661

Key Executives for Cantex Pharmaceuticals, Inc.

Chairman of The Board and Chief Executive Officer
Age: 71
President and Director
Compensation as of Fiscal Year 2015.

Cantex Pharmaceuticals, Inc. Key Developments

Cantex Pharmaceuticals, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 10:40 AM

Cantex Pharmaceuticals, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 10:40 AM. Venue: Westin Grand Central Hotel, New York, New York, United States.

Cantex Pharmaceuticals, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 11:15 AM

Cantex Pharmaceuticals, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 11:15 AM. Venue: Harbor Beach Marriott, Ft. Lauderdale, Florida, United States. Speakers: Stephen Marcus, President and Director.

ParinGenix, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013

ParinGenix, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 . Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
Primordial Genetics, Inc. United States
Biophile, Inc. United States
ITL Laboratories LLC United States
PerOs Systems Technologies, Inc. United States
AureoGen Biosciences, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cantex Pharmaceuticals, Inc., please visit www.cantex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.